Compound 2195
Identifiers
- Canonical SMILES:
Cc1cc(N=Nc2cccc(c2)S(=O)(=O)Nc2ccccn2)c(N)cc1O
- IUPAC name:
3-[2-(2-amino-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C18H17N5O3S/c1-12-9-16(15(19)11-17(12)24)22-21-13-5-4-6-14(10-13)27(25,26)23-18-7-2-3-8-20-18/h2-11,24H,19H2,1H3,(H,20,23)
- InChiKey:
JZTICAHMECMHKG-UHFFFAOYSA-N
External links
![]() 168317859 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 383.11 g/mol | |||
HBA | 8 | |||
HBD | 4 | |||
HBA + HBD | 12 | |||
AlogP | 3.62 | |||
TPSA | 127.23 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7612 | Sulfasalazine | DB00795 | |
0.5932 | Sulfapyridine | DB00891 | |
0.4899 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DB07944 | |
0.4740 | ABT-751 | DB12254 | |
0.4638 | Sulfaquinoxaline | DB11464 | |
0.4610 | Sulfaethoxypyridazine | DB11462 | |
0.4600 | Sulfamethoxypyridazine | DB13773 | |
0.4496 | Sulfaperin | DB13320 | |
0.4489 | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | DB07056 | |
0.4485 | Sulfamethazine | DB01582 | |
0.4392 | Sulfachlorpyridazine | DB11461 | |
0.4365 | Sulfadiazine | DB00359 | |
0.4338 | Sulfameter | DB06821 | |
0.4338 | Sulfamerazine | DB01581 | |
0.4272 | Elismetrep | DB15287 |